DSE:ACI

Advanced Chemical Industries PLC. announcements

379 Dhaka Stock Exchange announcements for Advanced Chemical Industries PLC. (ACI) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (22).

  1. TCP offered to buy out the entire shareholding of Tetley ACI (BD) Ltd.

    (Continuation news of ACI): only, depending in part on performance under the said Sales & Distribution and Factory Lease agreements. ACI and TCP, together with TCP's parent company Tata Consumer Products UK Group Limited, intend to finalise and sign the Settlement Agreement shortly, and to complete the transfer of shares and entry into the transitional services agreements as soon as possible thereafter. (end)

    The first part of this announcement is missing from the archive.
  2. Resumption after record date

    Trading of the shares of the Company will resume on 20.11.2022 after record date.

  3. Suspension for Record date

    Trading of the shares of the Company will remain suspended on record date i.e., 17.11.2022

  4. Buy Confirmation of a Director

    M. Anis Ud Dowla, one of the Directors of the company, has further informed that he has completed his buying of 3,50,000 shares of the company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 07.11.2022.

  5. Q1 Financials

    (Continuation news of ACI): devaluation of local currency against US Dollar, led to the decline in consolidated profit compared to the same period of last year. The consequential results of decreased consolidated profit ultimately led to decrease in consolidated EPS. On the other hand, NOCFPS decreased mainly due to investment in working capital to facilitate business growth in coming months. (end)

    The first part of this announcement is missing from the archive.
  6. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 15.11.2022 to 16.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 17.11.2022.

  7. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2022 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.

  8. Buy Declaration of a Director

    M. Anis Ud Dowla, one of the Directors of the company, has expressed his intention to buy 3,50,000 shares of the company at prevailing market price (in the Block Market) through Dhaka Stock Exchange within next 30 working days as per Rule-4 of the BSEC (Substantial Acquisition of Shares and Takeovers), Rules, 2018.

  9. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (27.10.2022) following its corporate declaration.

  10. Dividend Declaration

    (Continuation news of ACI): or through doing anything so that the post-dividend retained earnings become negative or a debit balance; c. Bonus shares have been recommended for utilizing the retained earnings of the company as Capital for ongoing operations, i.e. working capital. (end)

    The first part of this announcement is missing from the archive.
  11. Update of Information

    (Continuation news of ACI): The Company has further requested the concerned Brokerage/DPs to provide the details (shareholder's name, BO ID, e-mail address, shareholding position, gross dividend receivable, applicable tax rate and net divided receivable) of their Margin Loan Holders who hold Company's share on the Record Date to share office or email to [email protected] along with DPs Bank details (account name, account number, routing No., etc.), latest by December 15, 2022. (end)

    The first part of this announcement is missing from the archive.
  12. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2022 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.

  13. Share Transmission of Deceased Director among his successors

    Referring to the BSEC letter No. SEC/SRMIC/94-36/287 dated June 30, 2022, the Company has informed that Mrs. Najma Dowla, one of the Directors of the company passed away on 28.07.2021. Her total holding 20,06,645 shares will be transmitted among his successors according to the Succession Certificate issued by the Honorable Court.

  14. Arrangement for Demerger and Merger subject to proper authorities' approval

    (Continuation news of ACI): under the provision of Section 228 & 229 of the Companies Act 1994 subject to the consent of Shareholders and Creditors of the respective companies and approval from the Honorable High Court Division of Supreme Court of Bangladesh to create distinct brand identity for ACI Premio Plastics Limited for the consumer and to connect the backward linkage operation of Premiaflex Plastics Limited to the Company. (end)

    The first part of this announcement is missing from the archive.
  15. Termination of Joint Venture Agreement for future expansion of the company

    (Continuation news of ACI): ordinary shares of Tk 10 (Ten) each at a consideration of BDT 600,000,000.00 (six hundred million) only, for alignment of the future expansion of the Company (Advanced Chemical Industries Limited). (end)

    The first part of this announcement is missing from the archive.
  16. Approval of the U.S. Food & Drug Administration

    The company has informed that ACI Healthcare Limited, one of the subsidiaries of ACI Limited obtained the U.S. Food & Drug Administration (FDA) approval for its Healthcare establishment at Tripordi, Sonargaon, Narayanganj for the manufacturing of Gabapentin capsules which will be exported to US market. It is to be mentioned that the Healthcare site is primarily dedicated for export. This will positively impact pharmaceutical export.

  17. Q3 Financials

    (Continuation news of ACI): The company also informed that the Group achieved a significant revenue growth which was mainly contributed by the sales growth in some of the business segments. The higher growth in consolidated revenue compared to the growth in expenses contributed to the increase in consolidated profit compared to the same period of last year. The consequential results of increase consolidated revenue and profit ultimately contributed to improve consolidated EPS and NOCFPS. (end)

    The first part of this announcement is missing from the archive.
  18. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2022 at 3:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.

  19. Q2 Financials

    (Continuation news of ACI): The company has also informed that consolidated EPS and NOCFPS improved due to sales growth in some of the business segments. The higher growth in consolidated revenue compared to the growth in expenses contributed to the increase in consolidated profit compared to the SPLY. (end)

    The first part of this announcement is missing from the archive.
  20. Dividend Disbursement

    The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.

  21. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2022 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.

  22. Dividend Disbursement

    The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2021 to the respective shareholders' BO Accounts on December 29, 2021.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.